Urotensin-Ii As a Promising Key-Point of Cardiovascular Disturbances Sequel

Urotensin-Ii As a Promising Key-Point of Cardiovascular Disturbances Sequel Publisher Pubmed

Avagimyan A¹ ; Kajaia A² ; Gabunia L² ; Ghambashidze K² ; Sulashvili N³ ; Ratiani L⁴ ; Heshmatghahdarijani K⁵ ; Sheibani M⁶ ; Aznauryan A⁴

Show Affiliations

1. Department of Pathological Anatomy and Clinical Morphology, Yerevan State Medical University after M, Heratsi, Armenia
2. Pharmacology Department, Tbilisi State Medical University, Tbilisi, Georgia
3. Pharmacology Department, Tbilisi Open University, Tbilisi, Georgia
4. Histology Department, Yerevan State Medical University after M, Yerevan, Heratsi, Armenia
5. Isfahan Cardiovascular Research Institute, Isfahan, Iran
6. Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Source: Current Problems in Cardiology Published:2022

Abstract

Arterial hypertension is a highly urgent problem of modern medicine since the crisis of blood pressure control remains open, due to the increasing number of uncontrolled arterial hypertension. Today, one of the most critical problems of cardiology is the study of the mechanisms of development and progression of arterial hypertension. Therefore, our international and multidisciplinary working group presents a vision of a new therapeutic target - urotensin II in the pathogenesis of arterial hypertension. Thus, this article reflects the concept of the Armenian, Georgian and Iranian medical schools. © 2021 Elsevier Inc.

Related Docs

1. Losartan: A Pharmacotherapy in Cardiovascular Disease, New Emirates Medical Journal (2024)

Style	Citing Format
MLA	Avagimyan A, et al.. "Urotensin-Ii As a Promising Key-Point of Cardiovascular Disturbances Sequel." Current Problems in Cardiology, vol. 47, no. 11, 2022, pp. -.
APA	Avagimyan A, Kajaia A, Gabunia L, Ghambashidze K, Sulashvili N, Ratiani L, Heshmatghahdarijani K, Sheibani M, Aznauryan A (2022). Urotensin-Ii As a Promising Key-Point of Cardiovascular Disturbances Sequel. Current Problems in Cardiology, 47(11), -.
Chicago	Avagimyan A, Kajaia A, Gabunia L, Ghambashidze K, Sulashvili N, Ratiani L, Heshmatghahdarijani K, Sheibani M, Aznauryan A. "Urotensin-Ii As a Promising Key-Point of Cardiovascular Disturbances Sequel." Current Problems in Cardiology 47, no. 11 (2022): -.
Harvard	Avagimyan A et al. (2022) 'Urotensin-Ii As a Promising Key-Point of Cardiovascular Disturbances Sequel', Current Problems in Cardiology, 47(11), pp. -.
Vancouver	Avagimyan A, Kajaia A, Gabunia L, Ghambashidze K, Sulashvili N, Ratiani L, et al.. Urotensin-Ii As a Promising Key-Point of Cardiovascular Disturbances Sequel. Current Problems in Cardiology. 2022;47(11):-.
BibTex	@article{ author = {Avagimyan A and Kajaia A and Gabunia L and Ghambashidze K and Sulashvili N and Ratiani L and Heshmatghahdarijani K and Sheibani M and Aznauryan A}, title = {Urotensin-Ii As a Promising Key-Point of Cardiovascular Disturbances Sequel}, journal = {Current Problems in Cardiology}, volume = {47}, number = {11}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Avagimyan A AU - Kajaia A AU - Gabunia L AU - Ghambashidze K AU - Sulashvili N AU - Ratiani L AU - Heshmatghahdarijani K AU - Sheibani M AU - Aznauryan A TI - Urotensin-Ii As a Promising Key-Point of Cardiovascular Disturbances Sequel JO - Current Problems in Cardiology VL - 47 IS - 11 SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract